1.
Prognostic value of immunotherapy in advanced non-small cell lung cancer based on baseline and dynamic changes in hemoglobin, albumin, and platelets. Biomol Biomed [Internet]. 2024 Jul. 14 [cited 2024 Sep. 1];. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/10833